211 related articles for article (PubMed ID: 27255520)
1. The Diagnosis of Metastatic Axillary Lymph Nodes of Breast Cancer By Diffusion Weighted Imaging: a meta-analysis and systematic review.
Sui WF; Chen X; Peng ZK; Ye J; Wu JT
World J Surg Oncol; 2016 Jun; 14(1):155. PubMed ID: 27255520
[TBL] [Abstract][Full Text] [Related]
2. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
3. Diffusion weighted images of metastatic as compared with nonmetastatic axillary lymph nodes in patients with newly diagnosed breast cancer.
Yamaguchi K; Schacht D; Nakazono T; Irie H; Abe H
J Magn Reson Imaging; 2015 Sep; 42(3):771-8. PubMed ID: 25556886
[TBL] [Abstract][Full Text] [Related]
4. Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients.
Luo N; Su D; Jin G; Liu L; Zhu X; Xie D; Liu Y
J Magn Reson Imaging; 2013 Oct; 38(4):824-8. PubMed ID: 23440958
[TBL] [Abstract][Full Text] [Related]
5. Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging.
Razek AA; Lattif MA; Denewer A; Farouk O; Nada N
Breast Cancer; 2016 May; 23(3):525-32. PubMed ID: 25763535
[TBL] [Abstract][Full Text] [Related]
6. Discrimination of axillary metastatic from nonmetastatic lymph nodes with PROPELLER diffusion-weighted MR imaging in a metastatic breast cancer model and its correlation with cellularity.
Junping W; Tongguo S; Yunting Z; Chunshui Y; Renju B
J Magn Reson Imaging; 2012 Sep; 36(3):624-31. PubMed ID: 22570219
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer.
Fornasa F; Nesoti MV; Bovo C; Bonavina MG
J Magn Reson Imaging; 2012 Oct; 36(4):858-64. PubMed ID: 22648570
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MR imaging increases diagnostic accuracy of breast MR imaging for predicting axillary metastases in breast cancer patients.
Guvenc I; Whitman GJ; Liu P; Yalniz C; Ma J; Dogan BE
Breast J; 2019 Jan; 25(1):47-55. PubMed ID: 30444286
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
Kim SH; Shin HJ; Shin KC; Chae EY; Choi WJ; Cha JH; Kim HH
Clin Breast Cancer; 2017 Apr; 17(2):154-163. PubMed ID: 27843006
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis between metastatic and non-metastatic lymph nodes using DW-MRI: a meta-analysis of diagnostic accuracy studies.
Zhou M; Lu B; Lv G; Tang Q; Zhu J; Li J; Shi K
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1119-30. PubMed ID: 25515409
[TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis of axillary inflammatory and metastatic lymph nodes in rabbit models by using diffusion-weighted imaging: compared with conventional magnetic resonance imaging.
Wang J; Liao Q; Zhang Y; Yu C; Bai R; Sun H
Korean J Radiol; 2012; 13(4):458-66. PubMed ID: 22778568
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of breast MRI for predicting metastatic axillary lymph nodes in breast cancer patients: diffusion-weighted MRI and conventional MRI.
Kim EJ; Kim SH; Kang BJ; Choi BG; Song BJ; Choi JJ
Magn Reson Imaging; 2014 Dec; 32(10):1230-6. PubMed ID: 25072504
[TBL] [Abstract][Full Text] [Related]
13. Does axillary lymph node size predict better metastatic involvement than apparent diffusion coefficient (ADC) value in women with newly diagnosed breast cancer?
Ramírez-Galván YA; Cardona-Huerta S; Elizondo-Riojas G; Álvarez-Villalobos NA; Campos-Coy MA; Ferrara-Chapa CM
Acta Radiol; 2020 Nov; 61(11):1494-1504. PubMed ID: 32064890
[TBL] [Abstract][Full Text] [Related]
14. Axillary lymph node metastasis detection by magnetic resonance imaging in patients with breast cancer: A meta-analysis.
Zhou P; Wei Y; Chen G; Guo L; Yan D; Wang Y
Thorac Cancer; 2018 Aug; 9(8):989-996. PubMed ID: 29877048
[TBL] [Abstract][Full Text] [Related]
15. The value of T2* in differentiating metastatic from benign axillary lymph nodes in patients with breast cancer--a preliminary in vivo study.
Li C; Meng S; Yang X; Wang J; Hu J
PLoS One; 2014; 9(1):e84038. PubMed ID: 24454715
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.
Seber T; Caglar E; Uylar T; Karaman N; Aktas E; Aribas BK
Clin Imaging; 2015; 39(5):856-62. PubMed ID: 26091745
[TBL] [Abstract][Full Text] [Related]
17. Preoperative axillary staging with 3.0-T breast MRI: clinical value of diffusion imaging and apparent diffusion coefficient.
Rautiainen S; Könönen M; Sironen R; Masarwah A; Sudah M; Hakumäki J; Vanninen R; Sutela A
PLoS One; 2015; 10(3):e0122516. PubMed ID: 25823016
[TBL] [Abstract][Full Text] [Related]
18. Meta analysis of lymph node metastasis of breast cancer patients: Clinical value of DWI and ADC value.
Xing H; Song CL; Li WJ
Eur J Radiol; 2016 Jun; 85(6):1132-7. PubMed ID: 27161063
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of Dedicated Axillary T2- and Diffusion-weighted MR Imaging for Nodal Staging in Breast Cancer.
Schipper RJ; Paiman ML; Beets-Tan RG; Nelemans PJ; de Vries B; Heuts EM; van de Vijver KK; Keymeulen KB; Brans B; Smidt ML; Lobbes MB
Radiology; 2015 May; 275(2):345-55. PubMed ID: 25513854
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience.
Kim JK; Kim KA; Park BW; Kim N; Cho KS
J Magn Reson Imaging; 2008 Sep; 28(3):714-9. PubMed ID: 18777531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
